Literature DB >> 4039949

Bile salt damage of egg phosphatidylcholine liposomes.

C J O'Connor, R G Wallace, K Iwamoto, T Taguchi, J Sunamoto.   

Abstract

Physiochemical damage of egg phosphatidylcholine liposomes, caused by the salts of three bile acids, chenodeoxycholic acid, ursodeoxycholic acid, and cholic acid, has been investigated. Of the three bile salts, that of chenodeoxycholic acid was the most destructive, and the effect of the damage was examined by monitoring the induced 6-carboxyfluorescein release from the liposomes. For all three of the bile salts and under the experimental conditions, the minimum (effective) concentrations causing the 6-carboxyfluorescein release were below their critical micelle concentrations. In the case of the salt of chenodeoxycholic acid, the presence of cholesterol in the liposomal bilayers did not show any significant effect on the induced 6-carboxyfluorescein release, while, for the salts of ursodeoxycholic acid and cholic acid, the presence of cholesterol tended to depress the release. Permeation of bile salts into the membranes of liposomal bilayers made these membranes more fluid, and this fluidity was monitored by measuring the change in fluorescence polarization using 1,6-diphenylhexatriene entrapped in the liposomes. Coating the liposomes with polysaccharides, to make them more hydrophobic, led to their easier lysis by the bile salts.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4039949     DOI: 10.1016/0005-2736(85)90072-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Protective effects of nonionic triblock copolymers on bile acid-mediated epithelial barrier disruption.

Authors:  Adam Edelstein; David Fink; Mark Musch; Vesta Valuckaite; Olga Zaborina; Simonida Grubjesic; Millicent A Firestone; Jeffrey B Matthews; John C Alverdy
Journal:  Shock       Date:  2011-11       Impact factor: 3.454

2.  Understanding detergent effects on lipid membranes: a model study of lysolipids.

Authors:  Jonas R Henriksen; Thomas L Andresen; Lise N Feldborg; Lars Duelund; John H Ipsen
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

3.  Crohn's disease as an immunodeficiency.

Authors:  Bu'Hussain Hayee; Farooq Z Rahman; Gavin Sewell; Andrew M Smith; Anthony W Segal
Journal:  Expert Rev Clin Immunol       Date:  2010-07       Impact factor: 4.473

Review 4.  Effects of dietary components on intestinal permeability in health and disease.

Authors:  Katayoun Khoshbin; Michael Camilleri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-09-09       Impact factor: 4.052

5.  Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice.

Authors:  Iván L Csanaky; Lauren M Aleksunes; Yuji Tanaka; Curtis D Klaassen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-06-04       Impact factor: 4.052

6.  Comparative evaluation of intragastric bile acids and hepatobiliary scintigraphy in the diagnosis of duodenogastric reflux.

Authors:  Teng-Fei Chen; Praveen K Yadav; Rui-Jin Wu; Wei-Hua Yu; Chang-Qin Liu; Hui Lin; Zhan-Ju Liu
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

7.  Unique inhibition of bile salt-induced apoptosis by lecithins and cytoprotective bile salts in immortalized mouse cholangiocytes.

Authors:  Daisuke Komichi; Susumu Tazuma; Tomoji Nishioka; Hideyuki Hyogo; Mizuho Une; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2003-12       Impact factor: 3.199

8.  GYY4137 Attenuates Sodium Deoxycholate-Induced Intestinal Barrier Injury Both In Vitro and In Vivo.

Authors:  Zeyang Chen; Jianqiang Tang; Pengyuan Wang; Jing Zhu; Yucun Liu
Journal:  Biomed Res Int       Date:  2019-10-13       Impact factor: 3.411

9.  Cefotaxime pharmacokinetics after oral application in the form of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanate microvesicles in rat.

Authors:  Svetlana Golocorbin-Kon; Momir Mikov; Mousab Arafat; Zika Lepojevic; Ivan Mikov; Majda Sahman-Zaimovic; Zdenko Tomic
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2009 Jan-Mar       Impact factor: 2.569

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.